Intraoperative neuromonitoring market seen topping $5.5B by 2030

The global intraoperative neuromonitoring market is projected to rise from $3.78 billion in 2025 to $4.08 billion in 2026, with growth tied to complex surgeries, patient safety concerns and AI-enabled signal analysis. The Business Research Company says North America led in 2025, while Asia-Pacific is poised for the fastest expansion through 2030.

Why it matters: - Intraoperative neuromonitoring is becoming more central to high-risk surgery because surgeons use it to track neural pathways in real time and reduce the chance of nerve damage. - Demand is rising as hospitals and surgical centers handle more complex procedures and prioritize patient safety outcomes. - The market’s growth signals broader adoption of monitoring tools, software and specialized clinical services across surgical care.

What happened: - The Business Research Company released its Intraoperative Neuromonitoring Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on August 12, 2026. - The report projects the market will grow from $3.78 billion in 2025 to $4.08 billion in 2026. - The report forecasts the market will reach $5.51 billion by 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report includes a free sample and a full report available online: Download the sample report and view the full market report.

The details: - Intraoperative neuromonitoring covers techniques used during neurosurgery, orthopedic, peripheral nerve and vascular procedures. - The technology continuously monitors vulnerable brain and nerve structures during surgery. - The monitoring helps surgeons identify potential neural damage before it becomes permanent. - Growth in 2025 and 2026 is linked to more complex neurosurgical procedures, wider use of spinal surgeries, greater awareness of neural injury prevention, expansion of surgical services in hospitals and more availability of specialized neuromonitoring professionals. - Forecast growth through 2030 is tied to demand for minimally invasive surgery, AI-assisted signal interpretation, outpatient surgery growth, higher investment in surgical technology and stronger focus on patient safety. - The report highlights wider adoption of multimodal neuromonitoring systems, improved real-time neural signal analysis, advanced monitoring software, expanded intraoperative monitoring services and greater emphasis on reducing surgical risks. - The report also says early diagnosis is a major market driver because accurate diagnostic devices help identify health issues sooner. - A July 2023 Health Foundation report said the number of people living with major illnesses in the UK is expected to rise by 2.5 million by 2040. - That UK forecast would mean nearly one in five adults is managing a major illness by 2040. - Other regions covered in the analysis include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies analysis and updated graphics and tables.

Between the lines: - The report points to a market shift from basic intraoperative monitoring toward more integrated systems that combine software, real-time analytics and multiple monitoring methods. - AI adoption appears to be moving from a future possibility to a practical tool for improving signal interpretation in operating rooms. - Regional growth patterns suggest mature markets are leading on adoption, while faster investment and surgical expansion are creating more upside in emerging healthcare systems.

What's next: - Market growth is likely to track the spread of minimally invasive and outpatient surgeries, where precise nerve monitoring can help control risk. - The next phase of competition will likely center on better software, stronger real-time analysis and broader service coverage in and outside hospitals. - Continued investment in surgical technology and patient safety programs should keep supporting demand through 2030.

The bottom line: - Intraoperative neuromonitoring is moving from a specialized add-on to a more essential part of complex surgery, with the market on pace to pass $5.5 billion by 2030.